332 related articles for article (PubMed ID: 16784415)
1. Treatment of erectile dysfunction in multiple sclerosis.
Landtblom AM
Expert Rev Neurother; 2006 Jun; 6(6):931-5. PubMed ID: 16784415
[TBL] [Abstract][Full Text] [Related]
2. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Sperling H; Lümmen G; Schneider T; Rübben H
Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
[TBL] [Abstract][Full Text] [Related]
3. Newer pharmacologic alternatives for erectile dysfunction.
Viera AJ; Clenney TL; Shenenberger DW; Green GF
Am Fam Physician; 1999 Sep; 60(4):1159-66, 1169, 1172. PubMed ID: 10507745
[TBL] [Abstract][Full Text] [Related]
4. [Erectile dysfunction].
Lyngdorf P
Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
[No Abstract] [Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic.
Armstrong DK; Convery A; Dinsmore WW
Ulster Med J; 1994 Apr; 63(1):18-22. PubMed ID: 8658990
[TBL] [Abstract][Full Text] [Related]
7. [Male sexual dysfunction].
Lukkarinen O; Tammela T
Duodecim; 2001; 117(19):1965-72. PubMed ID: 12181928
[No Abstract] [Full Text] [Related]
8. Clinical practice. Erectile dysfunction.
McVary KT
N Engl J Med; 2007 Dec; 357(24):2472-81. PubMed ID: 18077811
[No Abstract] [Full Text] [Related]
9. Say yes to intimacy. Treatment options for erectile dysfunction.
Rice D
Diabetes Self Manag; 2004; 21(4):81-2, 84, 86, 89. PubMed ID: 15346557
[No Abstract] [Full Text] [Related]
10. Use of prostaglandin E1 in the treatment of sexual impotence after heart transplantation: initial clinical experience.
Livi U; Faggian G; Sorbara C; Gambino A; Calabrò A; Artibani W; Bortolotti U; Pagano F
J Heart Lung Transplant; 1993; 12(3):484-6. PubMed ID: 8329422
[TBL] [Abstract][Full Text] [Related]
11. [Support permanent discount for Viagra and Cialis in MS! Specified subsidy according to the Danish model is justified].
Landtblom AM
Lakartidningen; 2004 Aug; 101(35):2666-7. PubMed ID: 15458225
[No Abstract] [Full Text] [Related]
12. [PGE1 program in erectile dysfunction: etiopathogenic and pharmacologic aspects].
Ruiz Rubio JL; Fernández González I; Ruiz Rojas JC; Sánchez Sánchez E; Bustamante Alarma S; Berenguer Sánchez A
Actas Urol Esp; 1996; 20(7):636-9. PubMed ID: 8975549
[TBL] [Abstract][Full Text] [Related]
13. Use of intracavernosal alprostadil in erectile dysfunction.
Gingell C
Hosp Med; 1998 Oct; 59(10):777. PubMed ID: 9850293
[TBL] [Abstract][Full Text] [Related]
14. [Conservative treatment of erectile dysfunction].
Papp G; Erdei E
Orv Hetil; 2003 Jun; 144(22):1061-6. PubMed ID: 12847815
[TBL] [Abstract][Full Text] [Related]
15. Erectile dysfunction in systemic sclerosis.
Walker UA; Tyndall A; Ruszat R
Ann Rheum Dis; 2009 Jul; 68(7):1083-5. PubMed ID: 19525406
[TBL] [Abstract][Full Text] [Related]
16. Current management of erectile dysfunction after cancer treatment.
Peltier A; van Velthoven R; Roumeguère T
Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in multiple sclerosis.
Valleroy ML; Kraft GH
Arch Phys Med Rehabil; 1984 Mar; 65(3):125-8. PubMed ID: 6703886
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of sexual dysfunction in women].
Hilmand CB; Gregersen N; Giraldi AG
Ugeskr Laeger; 2002 Oct; 164(41):4794-6. PubMed ID: 12407886
[No Abstract] [Full Text] [Related]
20. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
